Impact of disease modifying therapy on fatigue among multiple sclerosis patients

被引：0
作者：
Elkhooly, Mahmoud [1 ,2 ]
Raghib, Muhammad [1 ]
Lazar, Emily [1 ]
Lazar, Adam [1 ]
Liaquat, Zaima [1 ]
Martinez, Carla [1 ]
Rube, Jacob [1 ]
Bernitsas, Evanthia [1 ]
机构：
[1] Wayne State Univ, Neurol, Detroit, MI USA
[2] Minia Univ, Neurol & Psychiat, Al Minya, Egypt
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1620/2035
引用
收藏
页码：1028 / 1028
页数：1
相关论文
共 50 条
  • [31] PRIOR DISEASE-MODIFYING DRUG USE AMONG PATIENTS WITH MULTIPLE SCLEROSIS
    Phillips, A. L.
    Kozma, C. M.
    Lorenzo, R.
    Locklear, J.
    VALUE IN HEALTH, 2014, 17 (03) : A67 - A67
  • [32] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Tanuja Chitnis
    Neurotherapeutics, 2013, 10 : 89 - 96
  • [33] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Chitnis, Tanuja
    NEUROTHERAPEUTICS, 2013, 10 (01) : 89 - 96
  • [34] Prevalence of Treatment Interruptions for Disease Modifying Therapies among Patients with Multiple Sclerosis
    Lublin, F. D.
    Rossi, C.
    Le, H. H.
    Holiday, C.
    Lefebvre, P.
    Pilon, D.
    Keenan, A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 201 - 202
  • [35] Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis
    Erin E. Longbrake
    Becky J. Parks
    Anne H. Cross
    Current Neurology and Neuroscience Reports, 2013, 13
  • [36] An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis
    Vaughn, Caila
    Bushra, Aisha
    Kolb, Channa
    Weinstock-Guttman, Bianca
    CNS DRUGS, 2018, 32 (02) : 161 - 178
  • [37] Factors Affecting the Adherence to Disease-Modifying Therapy in Patients With Multiple Sclerosis
    von Gaudecker, Jane R.
    JOURNAL OF NEUROSCIENCE NURSING, 2018, 50 (05) : 302 - 302
  • [38] Disease Modifying Therapy Discontinuation in Patients with Multiple Sclerosis Over Age 60
    Hua, Le H.
    Fan, Huijun
    Conway, Devon
    Kinzy, Tyler G.
    Thompson, Nicolas
    NEUROLOGY, 2017, 88
  • [39] Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
    F. Schweitzer
    S. Laurent
    G. R. Fink
    Michael H. Barnett
    H. P. Hartung
    C. Warnke
    Journal of Neurology, 2021, 268 : 2379 - 2389
  • [40] Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
    Schweitzer, F.
    Laurent, S.
    Fink, G. R.
    Barnett, Michael H.
    Hartung, H. P.
    Warnke, C.
    JOURNAL OF NEUROLOGY, 2021, 268 (07) : 2379 - 2389
12345